doi:10.1016/j.celrep.2024.114501 28
In a Phase 2 trial, adults with obesity lost about 24% of their body weight after 48 weeks, the largest drop reported for this class so far
Receptor crosstalk & downstream signalling investigated for coordinated intracellular signalling through GLP-1, GIP, and glucagon receptors in metabolic research models
Glucagon-like Peptide-1: A focus on neurodegenerative diseases
It is classified as a triple incretin receptor agonist , meaning it simultaneously targets three hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
Get Your Case Evaluated: Free Consultation Whether you took Ozempic, Wegovy, Mounjaro, Zepbound , or another GLP-1 medication, if you developed serious complications, you may be entitled to significant compensation